Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-13T22:45:50.019Z Has data issue: false hasContentIssue false
  • English
  • Français

Outcomes and Impacts of 10-Year HTA Implementation in Taiwan

Published online by Cambridge University Press:  28 February 2019

Kai-Ling Kao ,
Li-Ying Huang ,
Yen-Hui Wu  and
Churn-Shiouh Gau
Kai-Ling Kao
Affiliation:
Division of Health Technology Assessment, Center for Drug Evaluation, Taiwan
Li-Ying Huang*
Affiliation:
Division of Health Technology Assessment, Center for Drug Evaluation, Taiwan
Yen-Hui Wu
Affiliation:
Division of Health Technology Assessment, Center for Drug Evaluation, Taiwan
Churn-Shiouh Gau*
Affiliation:
Executive Director Office, Center for Drug Evaluation, Taiwan
*
Author for correspondence: Li-Ying Huang, E-mail: [email protected]; Churn-Shiouh Gau, E-mail: [email protected]
Author for correspondence: Li-Ying Huang, E-mail: [email protected]; Churn-Shiouh Gau, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

In 2007, Taiwan began conducting health technology assessments (HTA) to support the National Health Insurance Administration (NHIA) in its reimbursement decisions for drugs, medical devices, and medical services.

Methods

In this study, the development, missions, and procedures of the implementation of HTA in Taiwan are briefly introduced. Moreover, the value of HTA is examined by reviewing the outcomes and impacts of recent HTA-related research projects, which are classified into five categories: (i) pharmaceutical products, (ii) medical procedures, (iii) medical devices, (iv) health policy, and (v) social care.

Results

Overall, the 10-year implementation of HTA has not only supported the government's decision making but also enhanced patient care. Furthermore, patient evidence has been highlighted, and patient care pathways have been transformed through patient involvement in HTA.

Conclusions

In conclusion, HTA's value has been determined by both government and social aspects in Taiwan.

Keywords

Health technology assessmentHTAHTA impactHealth careReimbursement decision
Type
Theme Submission
Information
International Journal of Technology Assessment in Health Care , Volume 35 , Issue 6 , 2019 , pp. 441 - 445
Copyright
Copyright © Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Chiu, W-T, Pwu, R-F, Gau, C-S (2015) Affordable health technology assessment in Taiwan: A model for middle-income countries. J Formos Med Assoc Taiwan Yi Zhi 114, 481–483.CrossRefGoogle Scholar
2.Center for Drug Evaluation, Taiwan (2008) Assessment services of HTA [Internet]. [cited March 28, 2018]. http://www.cde.org.tw/eng/HTA/business.Google Scholar
3.Ministry of Health and Welfare (2017) National Health Insurance Act [Internet]. [cited November 7, 2018]. https://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?PCode=L0060001.Google Scholar
4.Hsu, JC, Lu, CY (2015) The evolution of Taiwan's National Health Insurance drug reimbursement scheme. DARU 23, 15.CrossRefGoogle Scholar
5.NHIA (2016) PBRS meeting [Internet]. National Health Insurance Administration Ministy of Health and Welfare. [cited November 7, 2018]. https://www.nhi.gov.tw/Content_List.aspx? n=9D41B8F668340682&topn=D39E2B72B0BDFA15&Create=1.Google Scholar
6.NIHTA, Taiwan (2013) HTA working guidelines [Internet]. [cited March 28, 2018]. http://nihta.cde.org.tw/Service/Rule?id=3.Google Scholar
7.NHIA, Taiwan (2016) PBRS meeting minutes for drugs [Internet]. [cited March 15, 2018]. https://www.nhi.gov.tw/Content_List.aspx?n=7248506703B0E5E2&topn=3FC7D09599D25979&Create=1.Google Scholar
8.NHIA, Taiwan (2016) PBRS meeting minutes for medical service (2004–2018) [Internet]. [cited March 15, 2018]. https://www.nhi.gov.tw/Content_List.aspx?n=6F823AB71BCC1C04&topn=D39E2B72B0BDFA15&Create=1.Google Scholar
9.NHIA, Taiwan (2018) NHI reimbursement scheme for medical service [Internet]. [cited March 22, 2018]. https://www.nhi.gov.tw/Content_List.aspx?n=58ED9C8D8417D00B&topn=D39E2B72B0BDFA15&Create=1.Google Scholar
10.NHIA, Taiwan (2017) PBRS meeting minutes for medical devices [Internet]. [cited March 12, 2018]. https://www.nhi.gov.tw/Content_List.aspx?n=BC23751A6FC2EDF6&topn=3FC7D09599D25979&Create=1.Google Scholar
11.CDC, Taiwan (2013) CDC regulations (2013.12.31) [Internet]. [cited March 26, 2018]. http://www.cdc.gov.tw/professional/info.aspx?treeid=CF7F90DCBCD5718D&nowtreeid=0441F6EEB625A9C1&tid=C44864BD7F6DD4EF.Google Scholar